Blood Res.  2020 Dec;55(4):278-281. 10.5045/br.2020.2020230.

COVID-19 in a patient with chronic myelomonocytic leukemia: a twisting tale

• Jain A
• Jain A
• Prasad P
• Chaudhry S
• Sharma M
• Khunger JM
• Gupta DK
• Saluja S

• KMID: 2509967
• DOI: http://doi.org/10.5045/br.2020.2020230

Figure

• 

  Fig. 1 (A) Ramanowsky stained bone marrow smears showing myeloid series and monocytosis (×100), (B) Ramanowsky stained bone marrow smears showing marked myeloid hyperplasia with hypergranulations (×100), and (C) diagrammatic representation of the complete clinical course of the patient. Abbreviations: CMML, chronic myelomonocytic leukemia; FN, febrile neutropenia; GCSF, granulocyte colony stimulating factor; HCQ, hydroxychloroquine; NEC, neutropenic enterocolitis; SARS-CoV2, severe acute respiratory syndrome coronavirus 2; TLC, total leucocyte count.

Reference

1. Itzykson R, Fenaux P, Bowen D, et al. 2018; Diagnosis and treatment of chronic myelomonocytic leukemias in adults: recommendations from the European Hematology Association and the European LeukemiaNet. Hemasphere. 2:e150. DOI: 10.1097/HS9.0000000000000150. PMID: 31723789. PMCID: PMC6745959.

2. Niyongere S, Lucas N, Zhou JM, et al. 2019; Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML. Leukemia. 33:205–16. DOI: 10.1038/s41375-018-0203-0. PMID: 30026572.

3. Patel AB, Pettijohn EM, Abedin SM, Raps E, Deininger MW. 2019; Leukemoid reaction in chronic myelomonocytic leukemia patients undergoing surgery: perioperative management recommend-ations. Blood Adv. 3:952–5. DOI: 10.1182/bloodadvances.2019032300. PMID: 30923049. PMCID: PMC6457233.

4. Patnaik MM, Lasho T, Padron E, et al. 2020; Special considerations in the management of patients with myelodysplastic myndrome /myeloproliferative neoplasm overlap syndromes during the SARS-CoV-2 pandemic. Am J Hematol. 95:E203–8. DOI: 10.1002/ajh.25853. PMCID: PMC7267346. PMID: 32356322.

5. Araki T, Ohata S, Okamoto K, et al. 2019; A case of acquired haemophilia A in a patient with chronic myelomonocytic leukaemia. Case Rep Hematol. 2019:8612031. DOI: 10.1155/2019/8612031. PMID: 30937199. PMCID: PMC6415290.

6. Short NJ, Kantarjian H, Ravandi F, Daver N. 2019; Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia. Ther Adv Hematol. 10:2040620719827310. DOI: 10.1177/2040620719827310. PMID: 30800259. PMCID: PMC6378516.

7. Moore JB, June CH. 2020; Cytokine release syndrome in severe COVID-19. Science. 368:473–4. DOI: 10.1126/science.abb8925. PMID: 32303591.

8. Carter LJ, Garner LV, Smoot JW, et al. 2020; Assay techniques and test development for COVID-19 diagnosis. ACS Cent Sci. 6:591. DOI: 10.1021/acscentsci.0c00501. PMID: 32382657. PMCID: PMC7197457.

9. Jin XH, Zheng KI, Pan KH, Xie YP, Zheng MH. 2020; COVID-19 in a patient with chronic lymphocytic leukaemia. Lancet Haematol. 7:e351–2. DOI: 10.1016/S2352-3026(20)30074-0. PMID: 32220344. PMCID: PMC7118537.

10. Mina A, van Besien K, Platanias LC. 2020; Hematological manifestations of COVID-19. Leuk Lymphoma. 61:2790–8. DOI: 10.1080/10428194.2020.1788017. PMID: 32643489.

11. D'Amico F, Baumgart DC, Danese S, Peyrin-Biroulet L. 2020; Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention, and management. Clin Gastroenterol Hepatol. 18:1663–72. DOI: 10.1016/j.cgh.2020.04.001. PMID: 32278065. PMCID: PMC7141637.

12. Jin X, Lian JS, Hu JH, et al. 2020; Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 69:1002–9. DOI: 10.1136/gutjnl-2020-320926. PMID: 32213556. PMCID: PMC7133387.

13. Bernheim A, Mei X, Huang M, et al. 2020; Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology. 295:200463. DOI: 10.1148/radiol.2020200463. PMID: 32077789. PMCID: PMC7233369.

14. Felsenstein S, Herbert JA, McNamara PS, Hedrich CM. 2020; COVID-19: immunology and treatment options. Clin Immunol. 215:108448. DOI: 10.1016/j.clim.2020.108448. PMID: 32353634. PMCID: PMC7185015.

15. Wiedermann FJ. 2005; Acute lung injury during G-CSF-induced neutropenia recovery: effect of G-CSF on pro- and anti-inflammatory cytokines. Bone Marrow Transplant. 36:731. DOI: 10.1038/sj.bmt.1705102. PMID: 16025149.

16. Nawar T, Morjaria S, Kaltsas A, et al. 2020; Granulocyte-colony stimulating factor in COVID-19: is it stimulating more than just the bone marrow? Am J Hematol. 95:E210–3. DOI: 10.1002/ajh.25870. PMID: 32419212. PMCID: PMC7276914.

17. Yang AP, Liu JP, Tao WQ, Li HM. 2020; The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 84:106504. DOI: 10.1016/j.intimp.2020.106504. PMID: 32304994. PMCID: PMC7152924.

18. Chopra J, Hiew HJ, Cumpstey A, Cagampang F, Jenner MW, Dushianthan A. 2020; Successful treatment of chronic myelomonocytic leukaemia with hydroxycarbamide in a patient presenting with acute hypoxic respiratory failure due to COVID-19 pneumonia. Br J Haematol. 190:c195–8. DOI: 10.1111/bjh.16978. PMID: 32593202. PMCID: PMC7362149.

19. National Comprehensive Cancer Network. 2020. Infectious disease management and considerations in cancer patients with documented or suspected COVID-19. National Comprehensive Cancer Network;Plymouth Meeting, PA: https://www.nccn.org/covid-19/pdf/COVID_Infections.pdf. Accessed August 3, 2020.